StockData
Elevance Health, Inc. logo

Elevance Health, Inc.

ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 21, 2026Score 15/3012% below fair value
$413.60−6.47 (-1.54%)

Close on Nov 2, 2026Market cap $89.70BP/E 18.4Yield –

Elevance Health Gross Medical Claims Payable, Ending Balance by Quarter

Gross Medical Claims Payable, Ending Balance ($M)

QuarterlyAnnual

Elevance Health Gross Medical Claims Payable, Ending Balance: $18,438M in Q3 2026, up 7.5% from a year earlier.

Latest, Q3 2026
18,438
Period ended Sep 30, 2026
Change on a year earlier
+7.5%
17,148 in Q3 2025
History
47 quarters
Since Q1 2015
Sources
3
Documents cited below

Where the Q3 2026 figure comes from

“us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense (2026-09-30): 18,438,000,000.00”

Source: ELV 10-Q (XBRL us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense) ↗

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedGross Medical Claims Payable, Ending Balance ($M)Year on yearSource
Q3 2026Sep 30, 202618,438+7.5%ELV 10-Q (XBRL us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense) ↗
Q2 2026Jun 30, 202618,463+7.6%ELV 10-Q (XBRL us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense) ↗
Q1 2026Mar 31, 202618,425+9.6%ELV 10-Q (XBRL us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense) ↗
Q4 2025Dec 31, 202517,084+8.5%ELV 10-Q (XBRL us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense) ↗
Q3 2025Sep 30, 202517,148+11.7%ELV 10-Q (XBRL us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense) ↗
Q2 2025Jun 30, 202517,155+12.8%ELV 10-Q (XBRL us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense) ↗
Q1 2025Mar 31, 202516,812+2.1%ELV 10-Q (XBRL us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense) ↗
Q4 2024Dec 31, 202415,746-2.3%ELV 10-K (XBRL us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense) ↗
Q3 2024Sep 30, 202415,346-5.1%ELV 10-Q (XBRL us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense) ↗
Q2 2024Jun 30, 202415,204-5.9%ELV 10-Q (XBRL us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense) ↗
Q1 2024Mar 31, 202416,459+4.6%ELV 10-Q (XBRL us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense) ↗
Q4 2023Dec 31, 202316,111+3.3%ELV 10-K (XBRL us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense) ↗
Q3 2023Sep 30, 202316,176+6.1%ELV 10-Q (XBRL us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense) ↗
Q2 2023Jun 30, 202316,165+6.9%ELV 10-Q/A (XBRL us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense) ↗
Q1 2023Mar 31, 202315,728+6.9%ELV 10-Q (XBRL us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense) ↗
Q4 2022Dec 31, 202215,596+15.4%ELV 10-K (XBRL us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense) ↗

Breakdown

What makes up gross Medical Claims Payable, Ending Balance

Cite this data

StockData. (2026). Elevance Health Gross Medical Claims Payable, Ending Balance ($M), quarterly Q1 2015–Q3 2026 [Data set]. Compiled from Elevance Health SEC filings and investor materials. https://stockdatahq.com/stocks/elv/kpis/mcp-gross-ending

See every metric in the Elevance Health KPI table. Data updated Oct 28, 2026.